Literature DB >> 30366635

ERCC2 Mutation: The Marker for Chemosensitivity in Primary and Secondary Muscle-invasive Bladder Cancers.

Woonyoung Choi1, David J McConkey2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30366635     DOI: 10.1016/j.eururo.2018.09.043

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  2 in total

Review 1.  Genomic Subtyping in Bladder Cancer.

Authors:  Tuomas Jalanko; Joep J de Jong; Ewan A Gibb; Roland Seiler; Peter C Black
Journal:  Curr Urol Rep       Date:  2020-03-13       Impact factor: 3.092

2.  IGFBP-2 acts as a tumour suppressor and plays a role in determining chemosensitivity in bladder cancer cells.

Authors:  Zhen Tang; David Gillatt; Edward Rowe; Anthony Koupparis; Jeff M P Holly; Claire M Perks
Journal:  Oncotarget       Date:  2019-12-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.